Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17114590 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
Condition: Macular Degeneration
Intervention:

Study has passed its completion date and status has not been verified in more than two years.